Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using
exemestane or tamoxifen may fight breast cancer by blocking the uptake of estrogen. It is not
yet known whether exemestane is more effective than tamoxifen in treating breast cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of exemestane with that of
tamoxifen in treating postmenopausal women with primary breast cancer who have already
received 2-3 years of tamoxifen following surgery.
Phase:
Phase 3
Details
Lead Sponsor:
International Collaborative Cancer Group
Collaborators:
European Organisation for Research and Treatment of Cancer - EORTC UNICANCER